Acrivon Therapeutics amends EVP Kristina Masson's employment agreement with $382,200 base salary

Acrivon Therapeutics, Inc.

Amended employment agreement with Kristina M. Masson, EVP of Business Operations and board member, effective June 1, 2023.
Base salary set at $382,200; target annual bonus up to 40% of salary.
Separate Swedish employment agreement for role as President/CEO of Acrivon AB with base salary $163,800.
Severance: if terminated without cause or for good reason, 9 months base salary plus pro-rata bonus; enhanced terms after change of control.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.